| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Bo Liu | |
| Di Wu | |||
| Wei Liu | |||
| Yi Shen | |||
| Guillermo A Ameer | |||
| Michael J Lee | |||
| Russell R Reid | |||
| Tong-Chuan He | |||
| Ling Zhao | |||
| Rex C Haydon | |||
| Mingyang Li | |||
| Zhenyu Ye | |||
| Aravind Athiviraham | |||
| Jennifer Moriatis Wolf | |||
| Daigui Cao | |||
| Yixiao Feng | |||
| Alexander J Li | |||
| Lewis Shi | |||
| Alison Deng | |||
| Alissa Li | |||
| Elam Coalson | |||
| Elliot Bishop | |||
| Mia Spezia | |||
| Ofir Hagag | |||
| Scott Du | |||
| Winny Liu | |||
| P2860 | cites work | Hyperbaric oxygen therapy for chronic wounds | Q24247431 |
| Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene | Q24324199 | ||
| Pathobiology of the stratum corneum | Q24539142 | ||
| Stem Cells in Skin Regeneration, Wound Healing, and Their Clinical Applications | Q26778010 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views | Q28251015 | ||
| The bone marrow is akin to skin: HCELL and the biology of hematopoietic stem cell homing | Q28261439 | ||
| Living with a venous leg ulcer: a descriptive study of patients' experiences | Q28283067 | ||
| Human mesenchymal stem cells modulate allogeneic immune cell responses | Q28288692 | ||
| Molecular mechanisms and clinical applications of angiogenesis | Q29547314 | ||
| Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes | Q29614341 | ||
| Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells | Q77739043 | ||
| Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-I, bFGF and PDGF-AB compared to controls | Q78074752 | ||
| Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures | Q78570627 | ||
| Biochemical analysis of acute and chronic wound environments | Q79440616 | ||
| Locally applied mononuclear bone marrow cells restore angiogenesis and promote wound healing in a type 2 diabetic patient | Q81371713 | ||
| Old bone marrow cells inhibit skin wound vascularization | Q81441096 | ||
| Human mesenchymal stem cells are tolerized by mice and improve skin and spinal cord injuries | Q81610505 | ||
| Wound dressings | Q83019688 | ||
| Characterization of urine-derived cells from upper urinary tract in patients with bladder cancer | Q83549094 | ||
| Economic Costs of Diabetes in the U.S. in 2017 | Q88137464 | ||
| Surface-structured bacterial cellulose loaded with hUSCs accelerate skin wound healing by promoting angiogenesis in rats | Q91718546 | ||
| Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells | Q94946139 | ||
| Regulation of wound healing by growth factors and cytokines | Q29615242 | ||
| Mechanisms of angiogenesis and arteriogenesis | Q29617257 | ||
| Wound repair and regeneration | Q29617949 | ||
| MicroSAGE analysis of 2,353 expressed genes in a single cell-derived colony of undifferentiated human mesenchymal stem cells reveals mRNAs of multiple cell lineages | Q30715810 | ||
| Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation | Q33293158 | ||
| Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing | Q33326623 | ||
| The effect of thrombocytopenia on dermal wound healing | Q33348310 | ||
| Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer. | Q33389973 | ||
| Cell therapy based on adipose tissue-derived stromal cells promotes physiological and pathological wound healing. | Q33406811 | ||
| Mechanisms and clinical applications of the vacuum-assisted closure (VAC) Device: a review | Q33433523 | ||
| Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers | Q33480699 | ||
| Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling | Q33649290 | ||
| Chronic leg ulcers: an underestimated problem in primary health care among elderly patients | Q33705430 | ||
| Extracellular matrix remodelling and cellular differentiation | Q33744976 | ||
| Epigenetic and phenotypic profile of fibroblasts derived from induced pluripotent stem cells | Q33840774 | ||
| Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization | Q33870103 | ||
| Nanofiber-expanded human umbilical cord blood-derived CD34+ cell therapy accelerates murine cutaneous wound closure by attenuating pro-inflammatory factors and secreting IL-10. | Q33876922 | ||
| Alpha 6 beta 4 integrin heterodimer is a component of hemidesmosomes | Q33899956 | ||
| Wound bed preparation: a systematic approach to wound management | Q34185664 | ||
| Funding translational work in cell-based therapy | Q34197298 | ||
| Distribution of Fibronectin During Wound Healing in Vivo | Q34282481 | ||
| The structure and biological features of fibrinogen and fibrin. | Q34311771 | ||
| 'See-saw' expression of microRNA-198 and FSTL1 from a single transcript in wound healing. | Q34327011 | ||
| Microvesicles derived from human umbilical cord mesenchymal stem cells stimulated by hypoxia promote angiogenesis both in vitro and in vivo | Q34354584 | ||
| Growth factors and wound healing: Part II. Role in normal and chronic wound healing | Q34356491 | ||
| Therapeutic angiogenesis and vasculogenesis for tissue regeneration | Q34404695 | ||
| Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair | Q34422297 | ||
| Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers | Q34570690 | ||
| Leg ulcers | Q34576970 | ||
| Anatomy, histology and immunohistochemistry of normal human skin | Q34719715 | ||
| Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study | Q34747226 | ||
| Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma | Q34805642 | ||
| Growth factors in the treatment of diabetic foot ulcers | Q35055787 | ||
| Treatment of pressure ulcers with autologous bone marrow nuclear cells in patients with spinal cord injury | Q35079904 | ||
| Severely impaired insulin signaling in chronic wounds of diabetic ob/ob mice: a potential role of tumor necrosis factor-alpha | Q35088035 | ||
| Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial | Q39273525 | ||
| Senescence and the healing rates of venous ulcers | Q39569595 | ||
| Safety and effect of adipose tissue-derived stem cell implantation in patients with critical limb ischemia: a pilot study | Q40030126 | ||
| VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling | Q40384240 | ||
| Human neural progenitors derived from integration-free iPSCs for SCI therapy | Q40387172 | ||
| Keratinization | Q40545986 | ||
| Progenitor cell therapy for sacral pressure sore: a pilot study with a novel human chronic wound model | Q40624030 | ||
| The wound healing process | Q40772617 | ||
| Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors | Q40907637 | ||
| Laminins: a family of diverse multifunctional molecules of basement membranes | Q40970625 | ||
| Platelet-derived growth factor BB for the treatment of chronic pressure ulcers | Q41873116 | ||
| Somatic epidermal stem cells can produce multiple cell lineages during development | Q42515898 | ||
| Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice | Q43470650 | ||
| Autologous transplantation of adipose-derived stem cells enhances skin graft survival and wound healing in diabetic rats | Q43600367 | ||
| "Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). | Q43897756 | ||
| Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. | Q44486370 | ||
| Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of Type 1 diabetic mice | Q44911364 | ||
| Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells | Q35098397 | ||
| Adipose-derived stem cells accelerate neovascularization in ischaemic diabetic skin flap via expression of hypoxia-inducible factor-1α. | Q35216306 | ||
| Negligible immunogenicity of induced pluripotent stem cells derived from human skin fibroblasts | Q35517873 | ||
| Estimating the costs associated with the management of patients with chronic wounds using linked routine data. | Q35589237 | ||
| Oxygen in wound healing and infection | Q35666367 | ||
| Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. | Q35691580 | ||
| Derivation of keratinocyte progenitor cells and skin formation from embryonic stem cells | Q35844861 | ||
| Chronic wounds | Q36090872 | ||
| Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue | Q36138509 | ||
| Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 1: normal and chronic wounds: biology, causes, and approaches to care | Q36190951 | ||
| Novel Insights on Understanding of Keloid Scar: Article Review | Q36239940 | ||
| The humanistic and economic burden of chronic wounds: a protocol for a systematic review | Q36259110 | ||
| Advanced Properties of Urine Derived Stem Cells Compared to Adipose Tissue Derived Stem Cells in Terms of Cell Proliferation, Immune Modulation and Multi Differentiation. | Q36400515 | ||
| Pathophysiology of acute wound healing | Q36727365 | ||
| Clinical application of growth factors and cytokines in wound healing | Q36742273 | ||
| Bone marrow-derived stem cells in wound healing: a review | Q36922408 | ||
| Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. | Q37133445 | ||
| Mesenchymal Stem Cell-Educated Macrophages Ameliorate LPS-Induced Systemic Response | Q37162881 | ||
| Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10. | Q37241672 | ||
| Ex vivo nanofiber expansion and genetic modification of human cord blood-derived progenitor/stem cells enhances vasculogenesis. | Q37358894 | ||
| Mesenchymal stem cells induce dermal fibroblast responses to injury | Q37455880 | ||
| A comparison of adipose and bone marrow-derived mesenchymal stromal cell secreted factors in the treatment of systemic inflammation | Q37493460 | ||
| Can hematopoietic stem cells be an alternative source for skin regeneration? | Q37505606 | ||
| Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages | Q37541334 | ||
| Exploring the role of stem cells in cutaneous wound healing | Q37589735 | ||
| Transplanted human bone marrow contributes to vascular endothelium | Q37695445 | ||
| Wound care: the role of advanced wound-healing technologies | Q37789558 | ||
| Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. | Q37999098 | ||
| Delivery of growth factors for tissue regeneration and wound healing | Q38002495 | ||
| Use of negative-pressure wound therapy in orthopaedic trauma | Q38039995 | ||
| Adipose stem cells: biology and clinical applications for tissue repair and regeneration | Q38173171 | ||
| Extracellular vesicles: potential roles in regenerative medicine | Q38292668 | ||
| Mesenchymal stem cells secrete immunologically active exosomes | Q39039982 | ||
| Chronic Wound Healing: A Review of Current Management and Treatments. | Q39097188 | ||
| Characterization, isolation, and differentiation of murine skin cells expressing hematopoietic stem cell markers | Q45861298 | ||
| Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease | Q45861396 | ||
| Differentiation of mouse induced pluripotent stem cells into a multipotent keratinocyte lineage | Q45865585 | ||
| Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness | Q45879145 | ||
| Sustained release of stromal cell derived factor-1 from an antioxidant thermoresponsive hydrogel enhances dermal wound healing in diabetes. | Q46508609 | ||
| Advances of Stem Cell Therapeutics in Cutaneous Wound Healing and Regeneration | Q47106642 | ||
| A Cooperative Copper Metal-Organic Framework-Hydrogel System Improves Wound Healing in Diabetes. | Q47134054 | ||
| Urine derived cells are a potential source for urological tissue reconstruction | Q47337447 | ||
| Bioglass enhanced wound healing ability of urine-derived stem cells through promoting paracrine effects between stem cells and recipient cells. | Q47662182 | ||
| Wound therapy by marrow mesenchymal cell transplantation | Q47870926 | ||
| Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type | Q47933679 | ||
| Hair follicle dermal stem cells regenerate the dermal sheath, repopulate the dermal papilla, and modulate hair type | Q48160301 | ||
| Adipose-derived stem cells seeded on acellular dermal matrix grafts enhance wound healing in a murine model of a full-thickness defect | Q48753460 | ||
| Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds | Q48910075 | ||
| Early passage autologous mesenchymal stromal cells accelerate diabetic wound re-epithelialization: A clinical case study | Q49550033 | ||
| Genetically-modified bone mesenchymal stem cells with TGF-β3 improve wound healing and reduce scar tissue formation in a rabbit model | Q49905312 | ||
| Adipose-Derived Stem Cells Accelerate Diabetic Wound Healing Through the Induction of Autocrine and Paracrine Effects. | Q50437110 | ||
| Bone marrow-derived mesenchymal stem cell attenuates skin fibrosis development in mice. | Q50483913 | ||
| Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. | Q50685836 | ||
| Stem cells. U.S. regulation of stem cells as medical products. | Q50771347 | ||
| Long-term bone marrow culture and its clinical potential in chronic wound healing. | Q50858934 | ||
| Diabetes impairs adipose tissue-derived stem cell function and efficiency in promoting wound healing. | Q51032524 | ||
| Bone marrow-derived endothelial progenitor cells do not contribute significantly to new vessels during incisional wound healing. | Q51063662 | ||
| Diabetes impairs endothelial progenitor cell-mediated blood vessel formation in response to hypoxia. | Q51080352 | ||
| Exosomal DMBT1 from human urine-derived stem cells facilitates diabetic wound repair by promoting angiogenesis. | Q51732915 | ||
| Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. | Q51775892 | ||
| Microvesicles derived from mesenchymal stem cells: potent organelles for induction of tolerogenic signaling. | Q53162462 | ||
| Longer-term changes in quality of life in chronic leg ulceration. | Q53224219 | ||
| Bone marrow-impregnated collagen matrix for wound healing: experimental evaluation in a microcirculatory model of angiogenesis, and clinical experience. | Q53664791 | ||
| Risk factors for delayed healing and recurrence of chronic venous leg ulcers--an analysis of 1324 legs. | Q54093254 | ||
| Cell therapy industry: billion dollar global business with unlimited potential. | Q55054226 | ||
| Urine-derived cells for human cell therapy. | Q55715290 | ||
| What is the physiological function of mast cells? | Q56984323 | ||
| The Safety and Effect of Topically Applied Recombinant Basic Fibroblast Growth Factor on the Healing of Chronic Pressure Sores | Q57465224 | ||
| Pharmacological Regulation of Oxidative Stress in Stem Cells | Q58604365 | ||
| Mesenchymal Stem Cells Alleviate Acute Lung Injury and Inflammatory Responses Induced by Paraquat Poisoning | Q64060338 | ||
| First-class delivery: getting growth factors to their destination | Q64376658 | ||
| Diabetic wound healing and limb salvage in an outpatient wound care program | Q70605385 | ||
| The differentiation of the dermis in the laboratory mouse | Q71315713 | ||
| Acceleration of wound healing in diabetic mice by basic fibroblast growth factor | Q71661568 | ||
| Effect of Topical Basic Fibroblast Growth Factor on the Healing of Chronic Diabetic Neuropathic Ulcer of the foot: A pilot, randomized, double-blind, placebo-controlled study | Q72113501 | ||
| Sequential appearance of fibronectin and collagen in experimental granulation tissue | Q72141127 | ||
| Growth factors and wound healing | Q72876260 | ||
| Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors | Q73075799 | ||
| Treatment of Chronic Wounds With Bone Marrow–Derived Cells | Q73299292 | ||
| Diabetic foot ulcers | Q73370844 | ||
| Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers | Q73665295 | ||
| Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation | Q73666640 | ||
| CD34+ blood cells accelerate vascularization and healing of diabetic mouse skin wounds | Q73734481 | ||
| Relative distribution and crosslinking of collagen distinguish fetal from adult sheep wound repair | Q74449131 | ||
| P433 | issue | 4 | |
| P921 | main subject | personalized medicine | Q2072214 |
| P304 | page(s) | 342-358 | |
| P577 | publication date | 2019-09-17 | |
| P1476 | title | Stem cell therapy for chronic skin wounds in the era of personalized medicine: From bench to bedside | |
| P478 | volume | 6 |
| Q98726609 | Role of stem cell therapies in treating chronic wounds: A systematic review | cites work | P2860 |
Search more.